Literature DB >> 9744541

Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma.

S R Goldstein1, G Y Yang, X Chen, S K Curtis, C S Yang.   

Abstract

A rat model was developed recently in our laboratory to study the pathogenesis of Barrett's esophagus (BE) and its progression to esophageal adenocarcinoma (EAC). Eight-week-old male Sprague-Dawley rats underwent esophagoduodenal anastomosis (EDA) to produce gastric and duodenal reflux in their distal esophagi. The rats were given iron dextran (50 mg of Fe/kg, i.p.) starting 2 weeks after surgery and this was continued once a month. BE was observed as early as week 3 and the incidence of BE and EAC increased with time: 58 and 17% at week 23; 91 and 73% at week 31. There was a progression in epithelial cell proliferation and inflammation from mild to severe in the distal one-third of the esophagus. Iron deposition in the esophagus also increased with time. Iron deposits in the stromal tissue adjacent to the epithelium in the distal one-third of the esophagus were associated with areas of severe inflammation. Immunohistochemical analysis showed positive inducible nitric oxide synthase (iNOS) expression in the stromal macrophages directly beneath the epithelium in the distal one-third of the esophagus in 36, 83 and 100% of the rats at weeks 17, 23 and 31, respectively. A significant increasing linear trend (P=0.001) was seen in nitrotyrosine immunostaining (number of positive cells/high power field) in the distal esophagus. Strong positive nitrotyrosine staining was seen in the macrophages and weaker positive staining was seen in the adjacent epithelium starting at week 17. Furthermore, iron supplemented rats killed at week 31 had significantly higher (P < 0.05) levels of inflammation, cell proliferation, iNOS and nitrotyrosine as well as more tumors in their distal esophagi than did rats that received no iron supplement. These results suggest that iron supplementation enhanced inflammation and the production of reactive oxygen and nitrogen species in the esophageal epithelium. These processes could contribute to the formation of BE and its progression to EAC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744541     DOI: 10.1093/carcin/19.8.1445

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

Review 1.  New models of neoplastic progression in Barrett's oesophagus.

Authors:  Kirill Pavlov; Carlo C Maley
Journal:  Biochem Soc Trans       Date:  2010-04       Impact factor: 5.407

2.  Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus.

Authors:  Elena Piazuelo; Carmelo Cebrián; Alfredo Escartín; Pilar Jiménez; Fernando Soteras; Javier Ortego; Angel Lanas
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

3.  Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma.

Authors:  Matthew F Buas; Haiwei Gu; Danijel Djukovic; Jiangjiang Zhu; Lynn Onstad; Brian J Reid; Daniel Raftery; Thomas L Vaughan
Journal:  Metabolomics       Date:  2017-01-20       Impact factor: 4.290

4.  Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus.

Authors:  Pilar Jiménez; Elena Piazuelo; M Teresa Sánchez; Javier Ortego; Fernando Soteras; Angel Lanas
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

5.  A comparative study of the iron status of patients with oesophageal adenocarcinoma to determine suitability for a clinical trial of iron chelation therapy.

Authors:  S J Ford; M R Bedford; W Pang; A Wood; T Iqbal; C Tselepis; O Tucker
Journal:  Ann R Coll Surg Engl       Date:  2014-05       Impact factor: 1.891

6.  Dietary fat and meat intakes and risk of reflux esophagitis, Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Mark G O'Doherty; Marie M Cantwell; Liam J Murray; Lesley A Anderson; Christian C Abnet
Journal:  Int J Cancer       Date:  2011-09-15       Impact factor: 7.396

7.  Expression of inducible nitric oxide synthase is increased in rat Barrett's esophagus induced by duodenal contents reflux.

Authors:  Jong Dae Bae; Ki Hoon Jung; Woo Sup Ahn; Sung Han Bae; Tae Jung Jang
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

8.  A rat surgical model of esophageal metaplasia and adenocarcinoma-induced by mixed reflux of gastric acid and duodenal contents.

Authors:  Tao Zhang; Feng Zhang; Yong Han; Zhongping Gu; Yong'an Zhou; Qingshu Cheng; Yifang Zhu; Chuanshan Zhang; Yunjie Wang
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

Review 9.  Animal Models of Barrett's Esophagus and Esophageal Adenocarcinoma-Past, Present, and Future.

Authors:  Harit Kapoor; Kush Raj Lohani; Tommy H Lee; Devendra K Agrawal; Sumeet K Mittal
Journal:  Clin Transl Sci       Date:  2015-07-27       Impact factor: 4.689

10.  Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice.

Authors:  Jing Hao; Ba Liu; Chung S Yang; Xiaoxin Chen
Journal:  BMC Gastroenterol       Date:  2009-07-23       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.